PH20985A - Oxindole antiinflammatory agents - Google Patents

Oxindole antiinflammatory agents

Info

Publication number
PH20985A
PH20985A PH33000A PH33000A PH20985A PH 20985 A PH20985 A PH 20985A PH 33000 A PH33000 A PH 33000A PH 33000 A PH33000 A PH 33000A PH 20985 A PH20985 A PH 20985A
Authority
PH
Philippines
Prior art keywords
oxindole
antiinflammatory agents
antiinflammatory
agents
oxindole antiinflammatory
Prior art date
Application number
PH33000A
Other languages
English (en)
Inventor
Melvin Lawrence Sherman Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/666,953 external-priority patent/US4644005A/en
Application filed by Pfizer filed Critical Pfizer
Publication of PH20985A publication Critical patent/PH20985A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH33000A 1984-10-31 1985-10-31 Oxindole antiinflammatory agents PH20985A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/666,953 US4644005A (en) 1984-10-31 1984-10-31 Oxindole antiinflammatory agents
US06/762,998 US4686224A (en) 1984-10-31 1985-08-06 Oxindole antiinflammatory agents

Publications (1)

Publication Number Publication Date
PH20985A true PH20985A (en) 1987-06-18

Family

ID=27099577

Family Applications (3)

Application Number Title Priority Date Filing Date
PH33000A PH20985A (en) 1984-10-31 1985-10-31 Oxindole antiinflammatory agents
PH34562A PH23130A (en) 1984-10-31 1986-12-05 Oxindole antiinflammatory agents
PH34563A PH24091A (en) 1984-10-31 1986-12-05 Oxindole antiinflammatory agents

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH34562A PH23130A (en) 1984-10-31 1986-12-05 Oxindole antiinflammatory agents
PH34563A PH24091A (en) 1984-10-31 1986-12-05 Oxindole antiinflammatory agents

Country Status (16)

Country Link
US (1) US4686224A (el)
EP (1) EP0181136B1 (el)
KR (1) KR870001269B1 (el)
AU (1) AU555051B2 (el)
CA (1) CA1247099A (el)
DE (1) DE3585719D1 (el)
DK (1) DK163990C (el)
ES (1) ES8707731A1 (el)
FI (1) FI81340C (el)
GR (1) GR852629B (el)
HU (1) HU194168B (el)
IE (1) IE58207B1 (el)
IL (1) IL76854A (el)
PH (3) PH20985A (el)
PL (2) PL145239B1 (el)
PT (1) PT81393B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217072B (hu) * 1989-01-10 1999-11-29 Pfizer Inc. 1-Heteroaril-oxindol-3-karboxamid-származékok, azok előállítása, és az azokat tartalmazó gyógyszerkészítmények
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
JPH0717589B2 (ja) * 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規1,3―ジカルボニル化合物およびその組成物
CH687764A5 (de) * 1992-07-02 1997-02-14 Lonza Ag Gampel Wallis Geschof Verfahren zur Herstellung von 7-Acylindolen.
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
CA2422342C (en) * 2000-09-14 2009-12-08 Mitsubishi Pharma Corporation Novel amide derivatives and medicinal use thereof
US7186745B2 (en) 2001-03-06 2007-03-06 Astrazeneca Ab Indolone derivatives having vascular damaging activity
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104130176A (zh) * 2014-06-13 2014-11-05 天津科技大学 一种1,5-二取代吲哚酮类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B (el) * 1984-03-19 1985-07-25 Pfizer

Also Published As

Publication number Publication date
PL145239B1 (en) 1988-08-31
PL255990A1 (en) 1987-03-23
DE3585719D1 (de) 1992-04-30
EP0181136B1 (en) 1992-03-25
US4686224A (en) 1987-08-11
PH23130A (en) 1989-05-05
DK163990B (da) 1992-04-27
ES8707731A1 (es) 1987-08-16
FI854258L (fi) 1986-05-01
IE58207B1 (en) 1993-07-28
IL76854A0 (en) 1986-02-28
AU4918985A (en) 1986-05-08
PT81393B (pt) 1988-02-17
AU555051B2 (en) 1986-09-11
FI81340B (fi) 1990-06-29
EP0181136A2 (en) 1986-05-14
DK497685A (da) 1986-05-01
KR860003260A (ko) 1986-05-21
PH24091A (en) 1990-03-05
EP0181136A3 (en) 1987-10-28
KR870001269B1 (ko) 1987-06-30
IE852703L (en) 1986-04-30
HUT39428A (en) 1986-09-29
HU194168B (en) 1988-01-28
CA1247099A (en) 1988-12-20
PL262327A1 (en) 1987-11-02
FI854258A0 (fi) 1985-10-30
DK497685D0 (da) 1985-10-30
ES554609A0 (es) 1987-08-16
IL76854A (en) 1989-05-15
PL150842B1 (en) 1990-07-31
DK163990C (da) 1992-09-21
FI81340C (fi) 1990-10-10
PT81393A (en) 1985-11-01
GR852629B (el) 1986-03-04

Similar Documents

Publication Publication Date Title
PH22850A (en) Indole derivatives
GB8519418D0 (en) Indole derivative
GB8614549D0 (en) Contrast agents
GB8613493D0 (en) Diester-dtpa-paramagnetic contrast agents
GB8513062D0 (en) Multidriver loudspeaker
DE3566333D1 (en) Phase-shifter
IL76854A0 (en) Oxindole antiinflammatory agents
GB2168973B (en) Indole derivatives
GB2168347B (en) Indoles
AU581469B2 (en) Fibrinolysis-enhancing agents
ZA854355B (en) Indole derivatives
PH25360A (en) Indole intermediates
AU92325S (en) Loudspeaker
GB2156398B (en) Two-part joist-hanger
AU5130885A (en) Diarylhydroxy-alkanones/alkenones antallergy agents
GB8427227D0 (en) Anti-nutation means
DE3572110D1 (en) Loudspeaker unit
ZA853007B (en) 3-substituted thiopyrones
GB8529238D0 (en) Agents
GB8403282D0 (en) Loudspeaker
ZA859244B (en) Indole derivatives
IE840135L (en) Indoles
IE842075L (en) Indoles
AU92339S (en) Loudspeaker
GB2167269B (en) Loudspeaker